Science Progress (1933-), Vol. 104, No. 1 (2021), pp. 1-16 (17 pages) Drug-induced liver injury (DILI) is one of the common adverse drug reactions and the leading cause of drug development attritions, ...

Abstract and Introduction Current Status of DILI Biomarkers Promising Avenues for Discovery of New DILI Biomarkers Next Steps References The lymphocyte transformation test is commercially available in ...

There is a pressing need for new clinical tests that will help physicians distinguish drug-induced liver injury (DILI) from other, more common causes of liver injury, and that can identify which ...

The integrated analysis of serum and fecal metabolites uncovers the significant disruption of bile acid metabolites as a key contributing factor in the pathogenesis of DILI. Our study offers promising ...

Caption The integrated analysis of serum and fecal metabolites uncovers the significant disruption of bile acid metabolites as a key contributing factor in the pathogenesis of DILI. Our study offers ...

Research and epidemiological studies will be implemented in China along with training and education. Pharmacogenomic services firm Gentris and the Shanghai Institutes of Preventive Medicine (SIPM) ...

There is uncertainty about whether biological and anthropometric measures that are clinical risk factors for disease are universally associated with chronological age, or whether these correlations ...

ALACHUA, Fla.--(BUSINESS WIRE)--Banyan Biomarkers, Inc. announced today that Mr. Nordhoff has been elected Executive Chairman of the Board for Banyan Biomarkers, Inc. Mr. Nordhoff joins Banyan ...